MX2024014602A - Metodo para producir particulas de virus adenoasociados (aav) recombinantes - Google Patents

Metodo para producir particulas de virus adenoasociados (aav) recombinantes

Info

Publication number
MX2024014602A
MX2024014602A MX2024014602A MX2024014602A MX2024014602A MX 2024014602 A MX2024014602 A MX 2024014602A MX 2024014602 A MX2024014602 A MX 2024014602A MX 2024014602 A MX2024014602 A MX 2024014602A MX 2024014602 A MX2024014602 A MX 2024014602A
Authority
MX
Mexico
Prior art keywords
recombinant aav
aav particle
cell solution
production cell
producing recombinant
Prior art date
Application number
MX2024014602A
Other languages
English (en)
Inventor
Sven Markert
Elisabeth Zollbrecht
Detlef Eisenkraetzer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2024014602A publication Critical patent/MX2024014602A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un método para producir una partícula de AAV recombinante que comprende las etapas de propagar una célula de mamífero mediante el uso de perfusión hasta que se obtiene al menos una primera densidad celular predeterminada; diluir una alícuota de las células propagadas mediante la adición de medio de cultivo fresco para obtener una solución de células de producción que tiene una segunda densidad celular predeterminada; cultivar la solución de células de producción durante 1 a 36 horas; transfectar las células directamente en la solución de células de producción cultivada con uno o más ácidos nucleicos que codifican la partícula de AAV recombinante; y cultivar la solución de células de producción transfectada durante 24 a 144 horas, con lo cual se produce una partícula de AAV recombinante.
MX2024014602A 2022-06-03 2024-11-26 Metodo para producir particulas de virus adenoasociados (aav) recombinantes MX2024014602A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22177118 2022-06-03
PCT/EP2023/064647 WO2023232922A1 (en) 2022-06-03 2023-06-01 Method for producing recombinant aav particles

Publications (1)

Publication Number Publication Date
MX2024014602A true MX2024014602A (es) 2025-01-09

Family

ID=82218399

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024014602A MX2024014602A (es) 2022-06-03 2024-11-26 Metodo para producir particulas de virus adenoasociados (aav) recombinantes

Country Status (11)

Country Link
US (1) US20250313854A1 (es)
EP (1) EP4532737A1 (es)
JP (1) JP2025519228A (es)
KR (1) KR20250020470A (es)
CN (1) CN119301260A (es)
AR (1) AR129500A1 (es)
AU (1) AU2023278422A1 (es)
CA (1) CA3258165A1 (es)
MX (1) MX2024014602A (es)
TW (1) TW202405182A (es)
WO (1) WO2023232922A1 (es)

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US6093699A (en) 1987-07-09 2000-07-25 The University Of Manitoba Method for gene therapy involving suppression of an immune response
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
ATE159548T1 (de) 1990-11-13 1997-11-15 Immunex Corp Bifunktionelle wählbare fusionsgene
US5587308A (en) 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
WO1994017810A1 (en) 1993-02-12 1994-08-18 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
WO1994023744A1 (en) 1993-04-16 1994-10-27 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
AU6953394A (en) 1993-05-21 1994-12-20 Targeted Genetics Corporation Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
US5998205A (en) 1994-11-28 1999-12-07 Genetic Therapy, Inc. Vectors for tissue-specific replication
US6100242A (en) 1995-02-28 2000-08-08 The Regents Of The University Of California Gene therapies for enhancing cardiac function
US6001650A (en) 1995-08-03 1999-12-14 Avigen, Inc. High-efficiency wild-type-free AAV helper functions
US6004797A (en) 1995-11-09 1999-12-21 Avigen, Inc. Adenovirus helper-free recombinant AAV Virion production
US6228646B1 (en) 1996-03-07 2001-05-08 The Regents Of The University Of California Helper-free, totally defective adenovirus for gene therapy
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
DE19955558C2 (de) 1999-11-18 2003-03-20 Stefan Kochanek Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren
AU2001257611A1 (en) 2000-04-28 2001-11-12 Avigen, Inc. Polynucleotides for use in recombinant adeno-associated virus virion production
US6593123B1 (en) 2000-08-07 2003-07-15 Avigen, Inc. Large-scale recombinant adeno-associated virus (rAAV) production and purification
JP4559429B2 (ja) 2003-05-21 2010-10-06 ジェンザイム・コーポレーション 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
DE102005054628A1 (de) 2005-11-16 2007-05-24 Cevec Pharmaceuticals Gmbh Verfahren zur Herstellung von permanenten humanen Zelllinien
EP2529020B1 (en) 2010-01-28 2018-04-25 The Children's Hospital of Philadelphia A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
EP3795581A3 (en) 2011-08-24 2021-06-09 The Board of Trustees of the Leland Stanford Junior University New avv capsid proteins for nucleic acid transfer
JP6342886B2 (ja) 2012-04-18 2018-06-13 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia Aavカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法
NZ716102A (en) 2013-07-22 2021-12-24 The Children’S Hospital Of Philadelphia Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
EP3384015A4 (en) 2015-12-01 2019-05-29 Spark Therapeutics, Inc. SCALABLE PROCESS FOR THE PREPARATION OF A RECOMBINANT ADENO ASSOCIATED VIRAL VECTOR IN A SERUM-FREE SUSPENSION CELL CULTURE SYSTEM SUITABLE FOR THE CLINICAL APPLICATION
WO2018226887A1 (en) 2017-06-07 2018-12-13 Spark Therapeutics, Inc. ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION
EP3658250A4 (en) 2017-06-30 2021-10-27 Spark Therapeutics, Inc. AAV VECTOR COLUMN CLEANING PROCEDURE
WO2020086408A1 (en) * 2018-10-26 2020-04-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A high-yield perfusion-based transient gene expression bioprocess
US20220098556A1 (en) 2019-01-25 2022-03-31 Biogen Ma Inc. Seed culture process for aav production
EP4006141A1 (en) * 2020-11-25 2022-06-01 CEVEC Pharmaceuticals GmbH Method for the production of aav

Also Published As

Publication number Publication date
AU2023278422A1 (en) 2024-11-14
JP2025519228A (ja) 2025-06-24
EP4532737A1 (en) 2025-04-09
AR129500A1 (es) 2024-09-04
US20250313854A1 (en) 2025-10-09
WO2023232922A1 (en) 2023-12-07
KR20250020470A (ko) 2025-02-11
TW202405182A (zh) 2024-02-01
CN119301260A (zh) 2025-01-10
CA3258165A1 (en) 2023-12-07

Similar Documents

Publication Publication Date Title
MX2020013633A (es) Metodos para producir proteinas recombinantes.
Paran et al. The continued requirement for inducer for the development of macrophage and granulocyte colonies
RU2009143635A (ru) Улучшение титра полипептида фактора viii в клеточных культурах
RU2008152449A (ru) Получение гликопротеинов
ATE359358T1 (de) Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden
ATE420198T1 (de) Methylotrophe hefe,die eine zuckerkette eines säugers herstellt
CO6491119A2 (es) Método de producción de un polipéptido o virus de interés en un cultivo celular contínuo
BR0311413A (pt) Desenvolvimento e transdiferenciação de células acinares humanas
RU98107565A (ru) Получение рекомбинантного фактора viii в среде, не содержащей белка
PT1002080E (pt) Proteinas fluorescentes como reporter especifico de tipo de celulas
AR052028A1 (es) Medio de cultivo de celula libre de suero para las celulas de los mamiferos
Polisetti et al. Efficient isolation and functional characterization of niche cells from human corneal limbus
Al-Shaibani Three-dimensional cell culture (3DCC) improves secretion of signaling molecules of mesenchymal stem cells (MSCs)
Egger et al. From 3D to 3D: isolation of mesenchymal stem/stromal cells into a three-dimensional human platelet lysate matrix
JPWO2022019306A5 (es)
CN115951057B (zh) 一种迁移体标记物
RU2014115731A (ru) Добавление железа для улучшения культивирования клеток
Bertoncello et al. Isolation and clonal assay of adult lung epithelial stem/progenitor cells
JP2022119210A5 (es)
Matsuura et al. Adequate taylor couette flow-mediated shear stress is useful for dissociating human iPS cell-derived cell aggregates
AR129500A1 (es) Método para producir partículas de aav recombinante
AR129895A1 (es) Método para producir partículas de aav recombinantes
CN104911104B (zh) 细胞及器官体外3‑d培养装置及人工器官培育的方法
Yu et al. Clonal isolation of human pluripotent stem cells on nanofibrous substrates reveals an advanced subclone for cardiomyocyte differentiation
CN107142236B (zh) 一种将胚胎肝内胆管上皮细胞诱导分化为含成熟胆管上皮细胞和胆管结构的细胞模型的方法